Literature DB >> 7605804

Cloning and sequence analysis of caprine N-acetylglucosamine 6-sulfatase cDNA.

K Friderici1, K T Cavanagh, J R Leipprandt, C E Traviss, D S Anson, J J Hopwood, M Z Jones.   

Abstract

Mucopolysaccharidosis IIID results from the deficiency of N-acetylglucosamine 6-sulfatase activity. A Nubian goat with this lysosomal storage disease has been identified. As a first step in developing this animal model for testing treatment methods, we cloned and sequenced the caprine N-acetylglucosamine 6-sulfatase cDNA coding region. Overall there is 88% nucleotide homology between the goat and human sequence and 94% homology of the deduced amino acid sequence. The human and two ruminant species differ by the presence of an imperfect trinucleotide (CCG) repeat in the ruminant signal sequence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605804     DOI: 10.1016/0925-4439(95)00054-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Caprine mucopolysaccharidosis IIID: a preliminary trial of enzyme replacement therapy.

Authors:  E Downs-Kelly; M Z Jones; J Alroy; K T Cavanagh; B King; R E Lucas; J C Baker; S A Kraemer; J J Hopwood
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

2.  Prenatal testing for caprine N-acetylglucosamine-6-sulphatase deficiency and sex identification.

Authors:  J R Leipprandt; K Friderici; D J Sprecher; M Z Jones
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Recombinant caprine 3H-[N-acetylglucosamine-6-sulfatase] and human 3H-[N-acetylgalactosamine-4-sulfatase]: plasma clearance, tissue distribution, and cellular uptake in the rat.

Authors:  M Z Jones; L K Brumfield; B M King; J J Hopwood; S Byers
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

4.  Expression, purification and characterization of recombinant caprine N-acetylglucosamine-6-sulphatase.

Authors:  T Litjens; J Bielicki; D S Anson; K Friderici; M Z Jones; J J Hopwood
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

5.  A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.

Authors:  N M Ellinwood; P Wang; T Skeen; N J H Sharp; M Cesta; S Decker; N J Edwards; I Bublot; J N Thompson; W Bush; E Hardam; M E Haskins; U Giger
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations.

Authors:  Margaret Z Jones; Joseph Alroy; Erinn Downs-Kelly; Rebecca E Lucas; Stacey A Kraemer; Kevin T Cavanagh; Barbara King; John J Hopwood
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 7.  Animal models for mucopolysaccharidosis disorders and their clinical relevance.

Authors:  Mark E Haskins
Journal:  Acta Paediatr       Date:  2007-04       Impact factor: 2.299

Review 8.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

9.  Matching the Diversity of Sulfated Biomolecules: Creation of a Classification Database for Sulfatases Reflecting Their Substrate Specificity.

Authors:  Tristan Barbeyron; Loraine Brillet-Guéguen; Wilfrid Carré; Cathelène Carrière; Christophe Caron; Mirjam Czjzek; Mark Hoebeke; Gurvan Michel
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.